158 related articles for article (PubMed ID: 27601357)
1. Aptamers against Cells Overexpressing Glypican 3 from Expanded Genetic Systems Combined with Cell Engineering and Laboratory Evolution.
Zhang L; Yang Z; Le Trinh T; Teng IT; Wang S; Bradley KM; Hoshika S; Wu Q; Cansiz S; Rowold DJ; McLendon C; Kim MS; Wu Y; Cui C; Liu Y; Hou W; Stewart K; Wan S; Liu C; Benner SA; Tan W
Angew Chem Int Ed Engl; 2016 Sep; 55(40):12372-5. PubMed ID: 27601357
[TBL] [Abstract][Full Text] [Related]
2. T Cells Engineered to Express a T-Cell Receptor Specific for Glypican-3 to Recognize and Kill Hepatoma Cells In Vitro and in Mice.
Dargel C; Bassani-Sternberg M; Hasreiter J; Zani F; Bockmann JH; Thiele F; Bohne F; Wisskirchen K; Wilde S; Sprinzl MF; Schendel DJ; Krackhardt AM; Uckert W; Wohlleber D; Schiemann M; Stemmer K; Heikenwälder M; Busch DH; Richter G; Mann M; Protzer U
Gastroenterology; 2015 Oct; 149(4):1042-52. PubMed ID: 26052074
[TBL] [Abstract][Full Text] [Related]
3. Customised nucleic acid libraries for enhanced aptamer selection and performance.
Pfeiffer F; Rosenthal M; Siegl J; Ewers J; Mayer G
Curr Opin Biotechnol; 2017 Dec; 48():111-118. PubMed ID: 28437710
[TBL] [Abstract][Full Text] [Related]
4. Glypican-3: a marker and a therapeutic target in hepatocellular carcinoma.
Filmus J; Capurro M
FEBS J; 2013 May; 280(10):2471-6. PubMed ID: 23305321
[TBL] [Abstract][Full Text] [Related]
5. Laboratory evolution of artificially expanded DNA gives redesignable aptamers that target the toxic form of anthrax protective antigen.
Biondi E; Lane JD; Das D; Dasgupta S; Piccirilli JA; Hoshika S; Bradley KM; Krantz BA; Benner SA
Nucleic Acids Res; 2016 Nov; 44(20):9565-9577. PubMed ID: 27701076
[TBL] [Abstract][Full Text] [Related]
6. An improved SELEX technique for selection of DNA aptamers binding to M-type 11 of Streptococcus pyogenes.
Hamula CL; Peng H; Wang Z; Tyrrell GJ; Li XF; Le XC
Methods; 2016 Mar; 97():51-7. PubMed ID: 26678795
[TBL] [Abstract][Full Text] [Related]
7. Imaging the expression of glypican-3 in hepatocellular carcinoma by PET.
Wang Z; Han YJ; Huang S; Wang M; Zhou WL; Li HS; Wang QS; Wu HB
Amino Acids; 2018 Feb; 50(2):309-320. PubMed ID: 29204748
[TBL] [Abstract][Full Text] [Related]
8. Evolving Aptamers with Unnatural Base Pairs.
Kimoto M; Matsunaga KI; Hirao I
Curr Protoc Chem Biol; 2017 Dec; 9(4):315-339. PubMed ID: 29241296
[TBL] [Abstract][Full Text] [Related]
9. Glypican-3 induces a mesenchymal to epithelial transition in human breast cancer cells.
Castillo LF; Tascón R; Lago Huvelle MR; Novack G; Llorens MC; Dos Santos AF; Shortrede J; Cabanillas AM; Bal de Kier Joffé E; Labriola L; Peters MG
Oncotarget; 2016 Sep; 7(37):60133-60154. PubMed ID: 27507057
[TBL] [Abstract][Full Text] [Related]
10. Gene silencing of glypican-3 in clear cell carcinoma of the ovary renders it more sensitive to the apoptotic agent paclitaxel in vitro and in vivo.
Umezu T; Shibata K; Shimaoka M; Kajiyama H; Yamamoto E; Ino K; Nawa A; Senga T; Kikkawa F
Cancer Sci; 2010 Jan; 101(1):143-8. PubMed ID: 19860840
[TBL] [Abstract][Full Text] [Related]
11. Novel Glypican-3-Binding Peptide for in Vivo Hepatocellular Carcinoma Fluorescent Imaging.
Zhu D; Qin Y; Wang J; Zhang L; Zou S; Zhu X; Zhu L
Bioconjug Chem; 2016 Mar; 27(3):831-9. PubMed ID: 26850086
[TBL] [Abstract][Full Text] [Related]
12. Biophysics of Artificially Expanded Genetic Information Systems. Thermodynamics of DNA Duplexes Containing Matches and Mismatches Involving 2-Amino-3-nitropyridin-6-one (Z) and Imidazo[1,2-a]-1,3,5-triazin-4(8H)one (P).
Wang X; Hoshika S; Peterson RJ; Kim MJ; Benner SA; Kahn JD
ACS Synth Biol; 2017 May; 6(5):782-792. PubMed ID: 28094993
[TBL] [Abstract][Full Text] [Related]
13. The oncofetal gene glypican 3 is regulated in the postnatal liver by zinc fingers and homeoboxes 2 and in the regenerating liver by alpha-fetoprotein regulator 2.
Morford LA; Davis C; Jin L; Dobierzewska A; Peterson ML; Spear BT
Hepatology; 2007 Nov; 46(5):1541-7. PubMed ID: 17668883
[TBL] [Abstract][Full Text] [Related]
14. Reduced nucleic ZHX2 involves in oncogenic activation of glypican 3 in human hepatocellular carcinoma.
Luan F; Liu P; Ma H; Yue X; Liu J; Gao L; Liang X; Ma C
Int J Biochem Cell Biol; 2014 Oct; 55():129-35. PubMed ID: 25195714
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of glypican-3 expression via RNA interference influences the growth and invasive ability of the MHCC97-H human hepatocellular carcinoma cell line.
Ruan J; Liu F; Chen X; Zhao P; Su N; Xie G; Chen J; Zheng D; Luo R
Int J Mol Med; 2011 Oct; 28(4):497-503. PubMed ID: 21617840
[TBL] [Abstract][Full Text] [Related]
16. Technical and biological issues relevant to cell typing with aptamers.
Li N; Ebright JN; Stovall GM; Chen X; Nguyen HH; Singh A; Syrett A; Ellington AD
J Proteome Res; 2009 May; 8(5):2438-48. PubMed ID: 19271740
[TBL] [Abstract][Full Text] [Related]
17. Glypican-3 inhibits Hedgehog signaling during development by competing with patched for Hedgehog binding.
Capurro MI; Xu P; Shi W; Li F; Jia A; Filmus J
Dev Cell; 2008 May; 14(5):700-11. PubMed ID: 18477453
[TBL] [Abstract][Full Text] [Related]
18. Glypican-3: A promising biomarker for hepatocellular carcinoma diagnosis and treatment.
Zhou F; Shang W; Yu X; Tian J
Med Res Rev; 2018 Mar; 38(2):741-767. PubMed ID: 28621802
[TBL] [Abstract][Full Text] [Related]
19. Selection and characterization of DNA aptamers specific for Listeria species.
Suh SH; Dwivedi HP; Choi SJ; Jaykus LA
Anal Biochem; 2014 Aug; 459():39-45. PubMed ID: 24857773
[TBL] [Abstract][Full Text] [Related]
20. Regulation of bone morphogenetic protein signalling and cranial osteogenesis by Gpc1 and Gpc3.
Dwivedi PP; Grose RH; Filmus J; Hii CS; Xian CJ; Anderson PJ; Powell BC
Bone; 2013 Aug; 55(2):367-76. PubMed ID: 23624389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
